| Price Chiropractic Center Chartered | |
|
9508 W Fairview Ave, Boise, ID 83704-8103 | |
| (208) 323-1313 | |
| (208) 323-1386 |
| Full Name | Price Chiropractic Center Chartered |
|---|---|
| Type | Facility |
| Speciality | Chiropractor - Orthopedic |
| Location | 9508 W Fairview Ave, Boise, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063826535 | NPI | - | NPPES |
| CHIA-452 | Other | ID | CHIROPRACTIC LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111NX0800X | Chiropractor - Orthopedic | CHIA-452 (Idaho) | Primary |
| Provider Name | Tyler Reidhead |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1750830345 PECOS PAC ID: 7719266725 Enrollment ID: I20161115002330 |
News Archive
Reallocation of treatment resources could substantially decrease the problem of unmet need for treatment of mental disorders among serious cases in developed and developing countries.
BerGenBio AS, an oncology biopharmaceutical company, announces that preclinical data demonstrating that BGB324 has potential application as a novel treatment for Chronic Myeloid Leukemia, was presented in a poster at the Annual Meeting of the American Society of Hematology, which took place on December 7-10, 2013.
Viron Therapeutics Inc., a biotechnology company pioneering the development of immune-modulating protein therapeutics derived from pathogens, today reported results from a Phase IIa clinical trial evaluating VT-111 (Serp-1), an anti-inflammatory protein derived from the myxoma virus.
Scientists at Albert Einstein College of Medicine of Yeshiva University have piggybacked antibodies onto radioactive payloads to deliver doses of radiation that selectively target and destroy microbial and HIV-infected cells.
"The federal government announced on Monday that it would reimburse American hospitals who treat Haitian earthquake victims with life-threatening injuries, making it possible for more hospitals in states outside Florida to consider taking those patients," the New York Times reports.
› Verified 3 days ago
| Provider Name | Erin Margaret Tuthill |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1285885343 PECOS PAC ID: 9133462351 Enrollment ID: I20190509002669 |
News Archive
Reallocation of treatment resources could substantially decrease the problem of unmet need for treatment of mental disorders among serious cases in developed and developing countries.
BerGenBio AS, an oncology biopharmaceutical company, announces that preclinical data demonstrating that BGB324 has potential application as a novel treatment for Chronic Myeloid Leukemia, was presented in a poster at the Annual Meeting of the American Society of Hematology, which took place on December 7-10, 2013.
Viron Therapeutics Inc., a biotechnology company pioneering the development of immune-modulating protein therapeutics derived from pathogens, today reported results from a Phase IIa clinical trial evaluating VT-111 (Serp-1), an anti-inflammatory protein derived from the myxoma virus.
Scientists at Albert Einstein College of Medicine of Yeshiva University have piggybacked antibodies onto radioactive payloads to deliver doses of radiation that selectively target and destroy microbial and HIV-infected cells.
"The federal government announced on Monday that it would reimburse American hospitals who treat Haitian earthquake victims with life-threatening injuries, making it possible for more hospitals in states outside Florida to consider taking those patients," the New York Times reports.
› Verified 3 days ago
| Provider Name | Raymond D Flack |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1235641374 PECOS PAC ID: 9537593439 Enrollment ID: I20191231002275 |
News Archive
Reallocation of treatment resources could substantially decrease the problem of unmet need for treatment of mental disorders among serious cases in developed and developing countries.
BerGenBio AS, an oncology biopharmaceutical company, announces that preclinical data demonstrating that BGB324 has potential application as a novel treatment for Chronic Myeloid Leukemia, was presented in a poster at the Annual Meeting of the American Society of Hematology, which took place on December 7-10, 2013.
Viron Therapeutics Inc., a biotechnology company pioneering the development of immune-modulating protein therapeutics derived from pathogens, today reported results from a Phase IIa clinical trial evaluating VT-111 (Serp-1), an anti-inflammatory protein derived from the myxoma virus.
Scientists at Albert Einstein College of Medicine of Yeshiva University have piggybacked antibodies onto radioactive payloads to deliver doses of radiation that selectively target and destroy microbial and HIV-infected cells.
"The federal government announced on Monday that it would reimburse American hospitals who treat Haitian earthquake victims with life-threatening injuries, making it possible for more hospitals in states outside Florida to consider taking those patients," the New York Times reports.
› Verified 3 days ago
| Provider Name | Jesse Sampogna |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1285258186 PECOS PAC ID: 2567884612 Enrollment ID: I20200625001308 |
News Archive
Reallocation of treatment resources could substantially decrease the problem of unmet need for treatment of mental disorders among serious cases in developed and developing countries.
BerGenBio AS, an oncology biopharmaceutical company, announces that preclinical data demonstrating that BGB324 has potential application as a novel treatment for Chronic Myeloid Leukemia, was presented in a poster at the Annual Meeting of the American Society of Hematology, which took place on December 7-10, 2013.
Viron Therapeutics Inc., a biotechnology company pioneering the development of immune-modulating protein therapeutics derived from pathogens, today reported results from a Phase IIa clinical trial evaluating VT-111 (Serp-1), an anti-inflammatory protein derived from the myxoma virus.
Scientists at Albert Einstein College of Medicine of Yeshiva University have piggybacked antibodies onto radioactive payloads to deliver doses of radiation that selectively target and destroy microbial and HIV-infected cells.
"The federal government announced on Monday that it would reimburse American hospitals who treat Haitian earthquake victims with life-threatening injuries, making it possible for more hospitals in states outside Florida to consider taking those patients," the New York Times reports.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Price Chiropractic Center Chartered 9508 W Fairview Ave, Boise, ID 83704-8103 Ph: (208) 323-1313 | Price Chiropractic Center Chartered 9508 W Fairview Ave, Boise, ID 83704-8103 Ph: (208) 323-1313 |
News Archive
Reallocation of treatment resources could substantially decrease the problem of unmet need for treatment of mental disorders among serious cases in developed and developing countries.
BerGenBio AS, an oncology biopharmaceutical company, announces that preclinical data demonstrating that BGB324 has potential application as a novel treatment for Chronic Myeloid Leukemia, was presented in a poster at the Annual Meeting of the American Society of Hematology, which took place on December 7-10, 2013.
Viron Therapeutics Inc., a biotechnology company pioneering the development of immune-modulating protein therapeutics derived from pathogens, today reported results from a Phase IIa clinical trial evaluating VT-111 (Serp-1), an anti-inflammatory protein derived from the myxoma virus.
Scientists at Albert Einstein College of Medicine of Yeshiva University have piggybacked antibodies onto radioactive payloads to deliver doses of radiation that selectively target and destroy microbial and HIV-infected cells.
"The federal government announced on Monday that it would reimburse American hospitals who treat Haitian earthquake victims with life-threatening injuries, making it possible for more hospitals in states outside Florida to consider taking those patients," the New York Times reports.
› Verified 3 days ago
Johnnie R Clemans, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 7805 Ustick Rd, Boise, ID 83704 Phone: 208-375-7851 Fax: 208-375-1905 | |
Century Clinic Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3062 N Five Mile Rd, Suite A, Boise, ID 83713 Phone: 208-377-9500 Fax: 208-377-8449 | |
Healthy Creations Inc Chiropractor Medicare: Medicare Enrolled Practice Location: 2999 N Lakeharbor Ln Ste 201, Boise, ID 83703 Phone: 208-853-2277 Fax: 208-853-2278 | |
Dr. Benjamin Webb, D.C Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 13909 W Wainwright Dr, Boise, ID 83713 Phone: 208-322-7900 | |
Dr. Gary D Musgrave, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3314 N. Cole Rd., Boise, ID 83704 Phone: 208-377-9930 Fax: 208-377-9932 | |
Dr. Luke A. Willett, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3040 N Five Mile Rd, Suite C, Boise, ID 83713 Phone: 208-321-8484 Fax: 208-321-5084 | |
Kyle Blevins, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 405 S 8th St Ste 290, Boise, ID 83702 Phone: 208-342-7136 |